TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC.

Tetsuya Mitsudomi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.